What is Incyte's EPS (diluted)?

Incyte (INCY) reported EPS (diluted) of $1.47 in Q1 2026.

How has Incyte's EPS (diluted) changed year-over-year?

Incyte's EPS (diluted) increased by 83.7% year-over-year, from $0.80 to $1.47.

What is the long-term trend for Incyte's EPS (diluted)?

Over 4 years (2021 to 2025), Incyte's EPS (diluted) has grown at a 10.7% compound annual growth rate (CAGR), from $4.27 to $6.41.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Incyte INCY EPS (Diluted)

EPS (Diluted) at other companies

BMY

BMYBMY

$1.31+9.2%

PfizerPFE

$0.47-9.6%

Celldex TherapeuticsCLDX

-$1.18-45.7%

Gilead SciencesGILD

$1.61+54.8%

GeronGERN

-$0.01+66.7%

Protagonist TherapeuticsPTGX

$0.05+126%

Other financials

Income statement

See full

Revenue$1.3B+20.9%

Gross profit$1.2B+19.2%

Operating income$301.1M+46.8%

Net income$303.3M+91.7%

Balance sheet

See full

Cash & equivalents$3.5B+78.2%

Total debt$39.4M-8.6%

Total equity$5.6B+53.3%

Total assets$7.3B+27.7%

Cash flow

See full

Operating cash flow$369.4M+38.8%

CapEx$1.6M-43.5%

Free cash flow$367.7M+39.7%

Valuation

See full

Market cap$23.32B+78.0%

Enterprise value$19.89B+77.9%

P/E16.3×+1.2×

P/S4.4×+1.5×

Profitability

See full

Gross margin92.5%-0.2pp

Operating margin30%+26.1pp

Net margin26.7%+26.2pp

FCF margin28.2%+19.7pp

Returns & leverage

See full

Return on equity30.8%+30.4pp

Debt / equity0×0.0×

Current ratio3.7×+1.6×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Incyte's EPS (diluted)?: Incyte (INCY) reported EPS (diluted) of $1.47 in Q1 2026.
How has Incyte's EPS (diluted) changed year-over-year?: Incyte's EPS (diluted) increased by 83.7% year-over-year, from $0.80 to $1.47.
What is the long-term trend for Incyte's EPS (diluted)?: Over 4 years (2021 to 2025), Incyte's EPS (diluted) has grown at a 10.7% compound annual growth rate (CAGR), from $4.27 to $6.41.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.